SCHEMBL13638355

SCHEMBL13638355

Cc1nnc(COCc2ccccc2)[nH]1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 1/20 0.54
ALDH1A1 P00352 3/20 0.39
CA1 P00915 1/20 0.39
CA2 P00918 1/20 0.39
CA7 P43166 1/20 0.39
CA9 Q16790 1/20 0.39
VCP P55072 1/20 0.38
L3MBTL1 Q9Y468 3/20 0.38
MAPT P10636 1/20 0.38
MAPK1 P28482 1/20 0.38
TDP1 Q9NUW8 1/20 0.38
NPC1 O15118 2/20 0.37
RAB9A P51151 2/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
BRD4 O60885 1/20 0.37
APP P05067 1/20 0.37
IDO1 P14902 1/20 0.36
TYMP P19971 1/20 0.36
TK1 P04183 1/20 0.36
HRH4 Q9H3N8 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL419212 0.79 GAA (0.48) TSHRALDH1A1NPC1RAB9ATYMP
SCHEMBL22272841 0.76 RAB9A (0.49) TSHRALDH1A1MAPTNPC1RAB9A
SCHEMBL27380 0.73 TSHR (1.00) TSHRALDH1A1CA1CA2CA7
Benzene SCHEMBL27997624 0.73 TSHR (1.00) TSHRALDH1A1CA1CA2CA7
SCHEMBL5311581 0.73 TSHR (1.00) TSHRALDH1A1CA1CA2CA7
SCHEMBL24105171 0.72 TSHR (0.50) TSHRALDH1A1CA1CA2CA7
P-Xylene SCHEMBL19206957 0.72 TSHR (0.75) TSHRALDH1A1CA1CA2CA7
Toluene SCHEMBL19206951 0.72 TSHR (0.75) TSHRALDH1A1CA1CA2CA7
O-Xylene SCHEMBL19206943 0.72 TSHR (0.75) TSHRALDH1A1CA1CA2CA7
SCHEMBL3959187 0.71 TSHR (0.54) TSHRCA1CA2CA7CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7615555-B2 Piperidine derivatives as modulators of chemokine receptor CCR5 ASTRAZENECA AB (SE) 2009-11-10 US disclosed
US-20070167442-A1 Chemical compounds ASTRAZENECA AB (SE) 2007-07-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070167442-A1 Chemical compounds CCR5, CXCR3, CX3CR1 TSHR 1875/4885ALDH1A1 586/4885CA1 1933/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.